Try our Advanced Search for more refined results

Deals Rumor Mill: Dow, Fosun Pharmaceutical, Anbang

By Benjamin Horney (July 31, 2017, 5:11 PM EDT) -- Multiple activist investors are planning to voice concerns regarding the megamerger of The Dow Chemical Co. and DuPont, with Dow Jones reporting on Monday that Jana Partners, Trian Fund Management LP, Glenview Capital Management and Third Point LLC are all critical of the deal. According to the report, the group is concerned with how the combined company will be divided. When the deal was announced in December 2015, the plan was to combine Dow and DuPont and then break that group into three separate entities....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!